My name is Porter Stansberry.
I’m the founder of one of the largest financial research firms in the world.
More than 16 million people from 100 countries read our work, and over the last 26 years we’ve helped investors navigate almost every major economic cycle.
We’ve also been on the forefront of every big financial story from the rise of Bitcoin and MRNA vaccines to robotics and artificial intelligence – just to name a few.
But I didn’t think I would ever live to see something like this.
Two Nobel Prize winners warn it’s a once-in-a-generation moment…
One that could dwarf the impact of the dot-com collapse, global financial crisis, and COVID-19 pandemic.
You see, our research indicates that displacements of this magnitude have only happened four times across the vast expanse of human history… and each one defined an entirely new epoch.
They’ve toppled and raised empires… started and ended wars… usurped kings... reshaped political systems… and lifted millions from poverty while condemning millions more to the poor house.
Now, I believe we’re living through another one.
And as you’ll see, I – and many of the world’s leading experts – believe this could be The Final Displacement.
As it unfolds, it threatens to upend every aspect of our daily lives from how we work, how we provide for loved ones to how we save and invest for the future.
Yet nobody is fully warning you of what’s coming. Until now.
In my new investigation, I reveal why I believe we are about to be plunged into a period of dramatic, almost unimaginable change.
One that will see politicians, companies, and economies rise and fall, the most sacred of our social contracts being rewritten, and our ways of life that’ve stood for generations being swept away in the blink of an eye.
And as you’ll see, history shows us that although these societal shifts always lead to catastrophic losses for those who fail to prepare…
… they also unleash unprecedented wealth building potential for those who understand, and harness, the forces at work.
And whether you ascend to an entirely new level of prosperity and freedom… or are left behind with your standards of living collapsing… that could depend on what you do today.
Because this wealth will only flow toward a select group of individuals… to those who understand the re-alignment we’re in and take the necessary steps to grasp it.
It’s already happening, with Goldman Sachs reporting an average of 1,600 new millionaires being created daily.
While at the same time, tens of millions of ordinary Americans are falling further and further behind…
Not because they’re lazy, reckless, or unwilling to work hard, but simply because they’re the unwitting victims of this Final Displacement.
Although you can’t stop these forces – no individual can – each of us can take steps that could dictate whether we’ll be crushed beneath them… or carried upward.
And whether you’re enriched or impoverished by this, could depend on what you do next… because while you might disagree with me about the scale or speed at which all of this will happen… there is no denying it is happening.
Today, I’m sharing everything my investigation uncovered.
Along with the steps I’m taking to protect myself, my loved ones, and my financial future… the steps that I’m certain will propel my wealth to an entirely new level.
And that I believe could do the same for your wealth.
Everything is detailed here for you in my new documentary.
Good investing,
Porter Stansberry
Palantir's New Healthcare Deal Boosts AI and Data Reach
Written by Chris Markoch. Published 10/15/2025.
Key Points
- Palantir partners with OneMedNet to power AI-based healthcare data analytics and real-world imaging research.
- The deal adds momentum to Palantir’s 93% growth in U.S. commercial revenue and expanding footprint in life sciences.
- Options data show strong bullish sentiment for PLTR stock ahead of its Nov. 3 earnings release.
Palantir Technologies Inc. (NASDAQ: PLTR) and OneMedNet Corp. (NASDAQ: ONMD) have agreed to a partnership that will leverage Palantir's Artificial Intelligence Platform (AIP) to enhance OneMedNet's healthcare AI and data analytics capabilities. Palantir's software will provide the infrastructure for OneMedNet's iRWD, a near-real-time AI-powered provider network.
The deal will help OneMedNet accelerate the use of real-world imaging data in clinical research. OneMedNet's network provides access to more than five billion administrative claims and 131 million clinical exams across over 1,750 provider sites, spanning oncology, cardiology and rare-disease care.
Partnership Strengthens Palantir's Role in Healthcare AI
Trump Devises the Death of the IRS ☠️ (Ad)
Trump has just signed an executive order creating America's first-ever National Investment Fund — a game-changing system designed to replace income taxes and send direct payouts to everyday Americans.
More than $1 TRILLION is expected to be distributed... and YOU could be eligible to claim a massive check.
This multi-year agreement deepens Palantir's footprint in the healthcare and life sciences sector, following prior collaborations with the FDA, NIH and leading pharmaceutical firms. It also strengthens Palantir's credibility in regulated health-data environments that require secure, compliant handling of sensitive information, including HIPAA-protected data.
The partnership further highlights how Palantir is positioning itself at the center of the AI-driven transformation of biomedical data management—an area that is attracting rapid investment and increasing regulatory attention.
Commercial Growth Shows Palantir's Expanding Reach
Until recently, critics argued Palantir relied too heavily on revenue from the U.S. government. In its most recent quarter, however, the company reported year-over-year U.S. commercial revenue growth of 93% and increased its commercial customer count by 64%.
Palantir says it's on track to deliver U.S. commercial revenue in excess of $1.302 billion, representing growth of at least 85%. About 44% of the company's total revenue now comes from its commercial business. The OneMedNet contract is not the only commercial win Palantir has announced since its last earnings report.
PLTR Stock Continues to Draw Institutional Interest
Over the last year, analysts have consistently raised their price targets for PLTR. At one point the consensus target was in the $60s, then the $80s; today MarketBeat's Palantir analyst forecasts show a consensus price target of $141.28. That represents about a 20% downside from its closing price on Oct. 14, though the gap was larger earlier in the year.
This underscores that investor behavior often matters more than headlines. It's fair to say Palantir trades at a premium, but commercial contracts such as the OneMedNet deal help explain why the market may be willing to pay that premium.
Bullish Options Activity Signals Confidence Before Earnings
PLTR is up more than 137% year-to-date in 2025 and about 20% over the last three months, making it a standout in the tech sector. That rally has cooled recently—up roughly 4.8% over the past month—as the stock consolidates in a range between roughly $173 and $187 following a strong run.
Such consolidation is common ahead of earnings. Palantir reports on Nov. 3, and a strong report would be a key catalyst to rekindle momentum.
While analysts have been relatively quiet, options traders are making bullish bets. The Palantir options chain for Nov. 7 (the Friday after the company's earnings report) shows notably higher call volume than put volume, particularly at strikes between $180 and $200, where open interest and implied volatility are elevated.
The $200 call leads with over 2,600 open contracts and rising interest (+633), suggesting some traders are positioning for continued upside.
That said, short interest in PLTR is up roughly 10% in the past month. If the company's earnings miss—or even merely meet—expectations, selling pressure could push the stock lower.
This email content is a paid advertisement for Porter & Company, a third-party advertiser of MarketBeat. Why did I get this email?.
If you have questions or concerns about your newsletter, feel free to email our South Dakota based support team at contact@marketbeat.com.
If you would no longer like to receive promotional emails from MarketBeat advertisers, you can unsubscribe or manage your mailing preferences here.
© 2006-2025 MarketBeat Media, LLC.
345 N Reid Place, Sixth Floor, Sioux Falls, SD 57103-7078. USA..